CW February 2002
Volume 11Issue Number 2 February 2002 ISSN 10593802 NHL: Fludarabine/Mitoxantrone/Rituximab ? IL-2/RituximabA strategy in advanced NHL of inducing remission with fludarabine and mitoxantrone followed by treatment with rituximab appears effective. Also, an early trial suggests that NK cell expansion with IL-2 increases rituximab efficacy in NHL.
Go to Previous Page Go to Next Page Source & Additional Reading S. Gregory, American Society of Hematology 43rd Annual Meeting and Exposition. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
